• Trials and Research

  Nerve Repair Therapy NVG-291 Safe, Well-tolerated in Healthy People

  Posted by John Connor on November 9, 2021 at 8:15 am

  NVG-291 may help rebuild myelin in MS patients.

  It’s currently going through the single ascending dose (SAD) part of the testing. As this has been very successful its developers are proposing it now move onto the multiple ascending dose (MAD) stage.

  Apart from the somewhat undermining medical acronyms, this looks like really promising news.

  Hope? What are your thoughts?

  John Connor replied 3 years ago 1 Member · 0 Replies

  • ms
  • myelin
  • NVG-291
• 0 Replies

Log In to Reply